Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
VolitionRX Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VNRX
American
8731
https://volition.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for VolitionRX Ltd
Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
- Apr 23rd, 2024 12:00 pm
VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for Sepsis
- Apr 8th, 2024 2:32 pm
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript
- Mar 27th, 2024 4:31 pm
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
- Mar 25th, 2024 8:10 pm
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
- Mar 21st, 2024 12:30 pm
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
- Mar 20th, 2024 12:30 pm
Volition appoints Dr Andrew Retter as Chief Medical Officer
- Mar 19th, 2024 8:30 pm
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
- Feb 2nd, 2024 1:00 pm
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances
- Jan 18th, 2024 9:54 am
Volition Issues Business Review 2023
- Jan 4th, 2024 1:00 pm
Sidoti Events, LLC's Virtual December Small-Cap Conference
- Dec 5th, 2023 3:25 pm
VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre
- Dec 5th, 2023 1:00 pm
VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript
- Nov 16th, 2023 2:15 pm
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update
- Nov 14th, 2023 9:10 pm
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update
- Nov 8th, 2023 1:00 pm
Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland
- Nov 6th, 2023 11:24 am
VNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & II
- Nov 2nd, 2023 12:19 pm
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer
- Oct 23rd, 2023 12:00 pm
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
- Oct 19th, 2023 12:00 pm
US Ambassador Adler visits Belgian Volition
- Oct 18th, 2023 4:00 pm
Scroll